‘Better decisions and shorter project timelines’: Optibrium taps InfoChem to up offering

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags: Drug discovery, Design, Software, Research, Preclinical contract research, Informatics

Optibrium develops software for drug discovery and today announces a collaboration with InfoChem GmbH, a cheminformatics company, to provide users with a computer-aided synthesis design tool.

According to the companies, the collaboration will provide users of StarDrop – Optibrium’s lead product – with access to ICSYNTH light, an entry-level version of InfoChem’s computer-aided synthesis design (CASD) software, which enables the generation of synthesis pathways for a target molecule.

Dr. Matthew Segall, Optibrium’s CEO told us the InfoChem’s deisgn tool will be a “valuable contribution to StarDrop’s comprehensive range of optional plug-in modules.”

Segall added, “StarDrop ensures that scientists can quickly understand structure-activity relationships, identify potential liabilities and design new compounds with the highest chance of success, leading to better decisions and shorter project timelines.”

Optibrium company works closely with a range of customers and collaborators, including global pharma, biotech, and academic groups, among others. Segall in a press release that the partnership with InfoChem “continues our collaborative approach to working with leading providers of technology and services for drug discovery and other chemistry fields."

“We have developed StarDrop to seamlessly connect with a wide range of informatics systems thus giving our customers ultimate choice and flexibility, and providing everything they need for effective compound design and optimization through a single interface,”​ he added.

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars